Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Seabra, M. Bignotto, Luciano Jr., S. Tufik (2000)
Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatmentJournal of Pineal Research, 29
S. Persengiev, S. Kyurkchiev (1993)
Selective effect of melatonin on the proliferation of lymphoid cells.The International journal of biochemistry, 25 3
S. Cos, D. Blask (1994)
Melatonin modulates growth factor activity in MCF‐7 human breast cancer cellsJournal of Pineal Research, 17
G. Jahnke, M. Marr, C. Myers, R. Wilson, G. Travlos, C. Price (1999)
Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats.Toxicological sciences : an official journal of the Society of Toxicology, 50 2
R. Reiter, D. Tan, B. Poeggeler, A. Menéndez‐peláez, Lidun Chen, S. Saarela (1994)
Melatonin As a Free Radical Scavenger: Implications for Aging and Age‐Related Diseases aAnnals of the New York Academy of Sciences, 719
(1984)
The pineal : An oncostatic gland ?
G. Maestroni (1993)
The immunoneuroendocrine role of melatoninJournal of Pineal Research, 14
A. Slominski, D. Pruski (1993)
Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells.Experimental cell research, 206 2
Shui-Wang Ying, L. Niles, Candice Crocker (1993)
Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin.European journal of pharmacology, 246 2
P. Lissoni, S. Barni, G. Cattaneo, G. Tancini, G. Esposti, D. Esposti, F. Fraschini (1991)
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies.Oncology, 48 6
A. Ross, P. Barrett, J. Mercer, P. Morgan (1996)
Melatonin suppresses the induction of AP-1 transcription factor components in the pars tuberalis of the pituitaryMolecular and Cellular Endocrinology, 123
S. Cos, E. Sánchez-Barceló (1995)
Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate.Cancer letters, 93 2
S. Cos, R. Verduga, C. Fernández-Viadero, M. Megias, D. Crespo (1996)
Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in cultureNeuroscience Letters, 216
(1999)
Mela - tonin - induced inhibition of proliferation and G 1 / S cell cycle transition dely of human choriocarcinoma Jar cells : Possible involvement of MT 2 ( MEL 1 B ) receptor
J. Petranka, W. Baldwin, Jennifer Biermann, S. Jayadev, J. Barrett, Elizabeth Murphy (1999)
The oncostatic action of melatonin in an ovarian carcinoma cell lineJournal of Pineal Research, 26
D. Ben‐Nathan, G. Maestroni, A. Conti (1997)
The Protective Effect of Melatonin in Viral and Bacterial Infections, 23
J. Chuang, N. Mohan, M. Meltz, R. Reiter (1996)
EFFECT OF MELATONIN ON NF‐κB DNA‐BINDING ACTIVITY IN THE RAT SPLEENCell Biology International, 20
T. Slater, B. Sawyer, U. Sträuli (1963)
STUDIES ON SUCCINATE-TETRAZOLIUM REDUCTASE SYSTEMS. III. POINTS OF COUPLING OF FOUR DIFFERENT TETRAZOLIUM SALTS.Biochimica et biophysica acta, 77
(2001)
The spectrum of melatonin actions in the direct detoxification of reactive oxygen and nitrogen species
M. Berridge, A. Tan (1993)
Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.Archives of biochemistry and biophysics, 303 2
ANGELI (1990) Melatonin and human cancer
D. Tan, L. Manchester, R. Reiter, W. Qi, M. Karbownik, J. Calvo (2000)
Significance of Melatonin in Antioxidative Defense System: Reactions and ProductsNeurosignals, 9
(1994)
5-Fluoracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells
R. Reiter (1998)
Oxidative damage in the central nervous system: protection by melatoninProgress in Neurobiology, 56
S. Mcnulty, A. Ross, P. Barrett, M. Hastings, P. Morgan (1994)
Melatonin Regulates the Phosphorylation of CREB in Ovine Pars Tuberalis *Journal of Neuroendocrinology, 6
(1995)
Melatonin ’ s inhibitory effect on growth of ME - 180 human cervical cancer cells is not related to intracellular glutathione levels
(1997)
Melatonin enhances IL-2, IL-6, and IFN-g production by human circulating CD4+ cells
S. Shiu, Li Li, Jian Xu, C. Pang, J. Wong, S. Pang (1999)
Melatonin‐induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: Possible involvement of MT2 (MEL1B) receptorJournal of Pineal Research, 27
Luigi Dogliotti, Alfredo Berruti, T. Buniva, M. Torta, A. Bottini, M. Tampellini, Massimo Terzolo, R. Faggiuolo, Alberto Angeli (1990)
Melatonin and human cancerThe Journal of Steroid Biochemistry and Molecular Biology, 37
R. Konakchieva, S. Kyurkchiev, I. Kehayov, P. Taushanova, L. Kanchev (1995)
Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cellsJournal of Neuroimmunology, 63
(1990)
In vitro effect of melatonin on cell cycle kinetics of mammary cancer cell lines ( Abstract )
I. Antolín, C. Rodríguez, R. Sainz, J. Mayo, H. Uría, M. Kotler, M. Rodríguez-Colunga, Deuo Tolivia, A. Menéndez‐peláez (1996)
Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymesThe FASEB Journal, 10
(1984)
The pineal: An oncostatic gland? In: The Pineal Gland
N. Mohan, K. Sadeghi, R. Reiter, M. Meltz (1995)
The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B.Biochemistry and molecular biology international, 37 6
A. Krishan (1975)
Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide stainingThe Journal of Cell Biology, 66
(1993)
Melatonin : A potent , endogenous hydroxyl radical scavenger
R. Reiter, D. Melchiorri, E. Sewerynek, B. Poeggeler, Lorneli Barlow‐Walden, Jih-Ing Chuang, G. Ortiz, Dario AcuñaCastroviejo (1995)
A review of the evidence supporting melatonin's role as an antioxidantJournal of Pineal Research, 18
T. Molis, L. Spriggs, Yolanda Jupiter, S. Hill (1995)
Melatonin modulation of estrogen‐regulated proteins, growth factors, and proto‐oncogenes in human breast cancerJournal of Pineal Research, 18
(1994)
5 - Fluoracil attenuates an oncostatic effect of melatonin on estrogen - sensitive human breast cancer cells ( MCF - 7 )
F. Lezoualc’h, M. Sparapani, C. Behl (1998)
N‐acetyl‐serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF‐κBJournal of Pineal Research, 24
S. Hill, L. Spriggs, M. Simón, Hitoyuki Muraoka, D. Blask (1992)
The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.Cancer letters, 64 3
D. Blask, Sean Wilson, F. Zalatan (1997)
Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway.Cancer research, 57 10
S. Hill, D. Blask (1988)
Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.Cancer research, 48 21
R. Reiter (2000)
Melatonin: Lowering the High Price of Free Radicals.News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society, 15
(1998)
N-acetylserotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kB
PRICE (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats
(1998)
A novel melatonin metabolite , cyclic 3 - hydroxymelatonin : a biomarker of melatonin interaction with hydroxyl radicals
(1995)
Mela - tonin blocks the stimulatory effects of prolactin of human breast cancer cells
S. Cos, D. Blask, Athena Lemus‐Wilson, A. Hill (1991)
Effects of melatonin on the cell cycle kinetics and “estrogen‐rescue” of MCF‐7 human breast cancer cells in cultureJournal of Pineal Research, 10
Sean Wilson, D. Blask, Athena Lemus‐Wilson (1992)
Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro.The Journal of clinical endocrinology and metabolism, 75 2
(1993)
ELF magnetic field , breast cancer , and melatonin : 60 Hz fields block melatonin ’ s oncostatic action on ER + breast cancer cell proliferation
R. Reiter (1980)
The pineal and its hormones in the control of reproduction in mammals.Endocrine reviews, 1 2
J. Jan, D. Hamilton, Nadine Seward, D. Fast, R. Freeman, M. Laudon (2000)
Clinical trials of controlled‐release melatonin in children with sleep–wake cycle disordersJournal of Pineal Research, 29
We have recently demonstrated that the pineal secretory product melatonin inhibits the key transcriptional regulator nuclear factor‐κB (NF‐κB). As the activation of NF‐κB is known to regulate the expression of cellular genes associated with cell cycle progression, cell growth, and differentiation, we investigated the effect of melatonin treatment on several cellular processes. These include cell viability, metabolic activity, and cell cycle phase distribution. Human embryonic kidney (293S) cells were treated with melatonin at concentrations of 0.02, 0.2, or 2 mM. When cell viability was measured 24, 48, and 72 hr after continuous exposure to melatonin using the trypan blue dye exclusion method, no significant cell death was observed. Even after exposure to 2 mM melatonin for 72 hr, cell viability remained at 98%. In contrast, another antioxidant compound, pyrrolidine dithiocarbomate (PDTC), at a 2 mM concentration reduced cell viability to 80.7±2.1% as early as 24 hr compared with untreated controls (P<0.05). When the metabolic activity was determined at 24, 48, and 72 hr using the colorimetric MTT assay, no significant changes in metabolic activity were observed. Even if the cells were treated with 10 mM melatonin for 72 hr, the metabolic activity was similar to that of the control cells. When cell cycle analysis was performed by flow cytometry, no marked difference in cell cycle distribution was observed. Melatonin at a concentration of 2 mM, however, did slightly alter the cell cycle (percentage of S phase cells) at 48 hr. This study revealed that when 293S cells are treated with concentrations of melatonin up to 2 mM, no significant alterations in three important cellular functions occurred. Exogenously added melatonin appeared to have a limited influence on the normal functioning of the cells even when the exposure continued for 72 hr.
Journal of Pineal Research – Wiley
Published: Oct 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.